Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Pantoprazole for Prevention of Rebleeding in Peptic Ulcer Hemorrhage
NCT00040495Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2001
- Primary completion
- Jan 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of pantoprazole in Peptic ulcer hemorrhage (PUB) (2 arms), sponsored by Pfizer. Primary endpoint: Rebleeding Rate at 30 days. Started Apr 2001; status: completed.
02
Drugs
pantoprazole
03
Conditions
Peptic ulcer hemorrhage (PUB)
Beyond the preview
Go deeper on NCT00040495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040495.